ANTIBODY BINDING TISSUE FACTOR PATHWAY INHIBITOR AND USE OF ANTIBODY
Provided is an antibody specifically binding a tissue factor pathway inhibitor in a pH-dependent manner or an antigen-binding fragment of the antibody, and also provided are a nucleic acid molecule encoding the antibody, an expression vector and a host cell for expressing the antibody, and a product...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WU, Cui ZHOU, Chi LI, Yuanli LI, Qiang CHEN, Si DIAO, Jiasheng SUN, Jianyu GAO, Yongjuan |
| description | Provided is an antibody specifically binding a tissue factor pathway inhibitor in a pH-dependent manner or an antigen-binding fragment of the antibody, and also provided are a nucleic acid molecule encoding the antibody, an expression vector and a host cell for expressing the antibody, and a production method for the antibody. In addition, also provided are a pharmaceutical composition comprising the antibody or the antigen-binding fragment thereof, and a use of the pharmaceutical composition in the preparation of patient therapeutic drugs for preventing and/or treating diseases such as genetic or acquired coagulation factor deficiency, Bernard-Soulier syndrome, and Glanzmann's thrombasthenia.
L'invention concerne un anticorps se liant spécifiquement à un inhibiteur de la voie du facteur tissulaire de manière dépendante du pH ou un fragment de liaison à l'antigène de l'anticorps, et l'invention concerne également une molécule d'acide nucléique codant pour l'anticorps, un vecteur d'expression et une cellule hô |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024250605A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024250605A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024250605A13</originalsourceid><addsrcrecordid>eNrjZHBx9AvxdPJ3iVRw8vRz8fRzVwjxDA4OdVVwc3QO8Q9SCHAM8Qh3jFTw9PPwdPIEiTj6uSiEBrsq-LspwPTyMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL4cH8jAyMTI1MDMwNTR0Nj4lQBAALALJU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIBODY BINDING TISSUE FACTOR PATHWAY INHIBITOR AND USE OF ANTIBODY</title><source>esp@cenet</source><creator>WU, Cui ; ZHOU, Chi ; LI, Yuanli ; LI, Qiang ; CHEN, Si ; DIAO, Jiasheng ; SUN, Jianyu ; GAO, Yongjuan</creator><creatorcontrib>WU, Cui ; ZHOU, Chi ; LI, Yuanli ; LI, Qiang ; CHEN, Si ; DIAO, Jiasheng ; SUN, Jianyu ; GAO, Yongjuan</creatorcontrib><description>Provided is an antibody specifically binding a tissue factor pathway inhibitor in a pH-dependent manner or an antigen-binding fragment of the antibody, and also provided are a nucleic acid molecule encoding the antibody, an expression vector and a host cell for expressing the antibody, and a production method for the antibody. In addition, also provided are a pharmaceutical composition comprising the antibody or the antigen-binding fragment thereof, and a use of the pharmaceutical composition in the preparation of patient therapeutic drugs for preventing and/or treating diseases such as genetic or acquired coagulation factor deficiency, Bernard-Soulier syndrome, and Glanzmann's thrombasthenia.
L'invention concerne un anticorps se liant spécifiquement à un inhibiteur de la voie du facteur tissulaire de manière dépendante du pH ou un fragment de liaison à l'antigène de l'anticorps, et l'invention concerne également une molécule d'acide nucléique codant pour l'anticorps, un vecteur d'expression et une cellule hô</description><language>chi ; eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241212&DB=EPODOC&CC=WO&NR=2024250605A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241212&DB=EPODOC&CC=WO&NR=2024250605A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WU, Cui</creatorcontrib><creatorcontrib>ZHOU, Chi</creatorcontrib><creatorcontrib>LI, Yuanli</creatorcontrib><creatorcontrib>LI, Qiang</creatorcontrib><creatorcontrib>CHEN, Si</creatorcontrib><creatorcontrib>DIAO, Jiasheng</creatorcontrib><creatorcontrib>SUN, Jianyu</creatorcontrib><creatorcontrib>GAO, Yongjuan</creatorcontrib><title>ANTIBODY BINDING TISSUE FACTOR PATHWAY INHIBITOR AND USE OF ANTIBODY</title><description>Provided is an antibody specifically binding a tissue factor pathway inhibitor in a pH-dependent manner or an antigen-binding fragment of the antibody, and also provided are a nucleic acid molecule encoding the antibody, an expression vector and a host cell for expressing the antibody, and a production method for the antibody. In addition, also provided are a pharmaceutical composition comprising the antibody or the antigen-binding fragment thereof, and a use of the pharmaceutical composition in the preparation of patient therapeutic drugs for preventing and/or treating diseases such as genetic or acquired coagulation factor deficiency, Bernard-Soulier syndrome, and Glanzmann's thrombasthenia.
L'invention concerne un anticorps se liant spécifiquement à un inhibiteur de la voie du facteur tissulaire de manière dépendante du pH ou un fragment de liaison à l'antigène de l'anticorps, et l'invention concerne également une molécule d'acide nucléique codant pour l'anticorps, un vecteur d'expression et une cellule hô</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHBx9AvxdPJ3iVRw8vRz8fRzVwjxDA4OdVVwc3QO8Q9SCHAM8Qh3jFTw9PPwdPIEiTj6uSiEBrsq-LspwPTyMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL4cH8jAyMTI1MDMwNTR0Nj4lQBAALALJU</recordid><startdate>20241212</startdate><enddate>20241212</enddate><creator>WU, Cui</creator><creator>ZHOU, Chi</creator><creator>LI, Yuanli</creator><creator>LI, Qiang</creator><creator>CHEN, Si</creator><creator>DIAO, Jiasheng</creator><creator>SUN, Jianyu</creator><creator>GAO, Yongjuan</creator><scope>EVB</scope></search><sort><creationdate>20241212</creationdate><title>ANTIBODY BINDING TISSUE FACTOR PATHWAY INHIBITOR AND USE OF ANTIBODY</title><author>WU, Cui ; ZHOU, Chi ; LI, Yuanli ; LI, Qiang ; CHEN, Si ; DIAO, Jiasheng ; SUN, Jianyu ; GAO, Yongjuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024250605A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng ; fre</language><creationdate>2024</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>WU, Cui</creatorcontrib><creatorcontrib>ZHOU, Chi</creatorcontrib><creatorcontrib>LI, Yuanli</creatorcontrib><creatorcontrib>LI, Qiang</creatorcontrib><creatorcontrib>CHEN, Si</creatorcontrib><creatorcontrib>DIAO, Jiasheng</creatorcontrib><creatorcontrib>SUN, Jianyu</creatorcontrib><creatorcontrib>GAO, Yongjuan</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WU, Cui</au><au>ZHOU, Chi</au><au>LI, Yuanli</au><au>LI, Qiang</au><au>CHEN, Si</au><au>DIAO, Jiasheng</au><au>SUN, Jianyu</au><au>GAO, Yongjuan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIBODY BINDING TISSUE FACTOR PATHWAY INHIBITOR AND USE OF ANTIBODY</title><date>2024-12-12</date><risdate>2024</risdate><abstract>Provided is an antibody specifically binding a tissue factor pathway inhibitor in a pH-dependent manner or an antigen-binding fragment of the antibody, and also provided are a nucleic acid molecule encoding the antibody, an expression vector and a host cell for expressing the antibody, and a production method for the antibody. In addition, also provided are a pharmaceutical composition comprising the antibody or the antigen-binding fragment thereof, and a use of the pharmaceutical composition in the preparation of patient therapeutic drugs for preventing and/or treating diseases such as genetic or acquired coagulation factor deficiency, Bernard-Soulier syndrome, and Glanzmann's thrombasthenia.
L'invention concerne un anticorps se liant spécifiquement à un inhibiteur de la voie du facteur tissulaire de manière dépendante du pH ou un fragment de liaison à l'antigène de l'anticorps, et l'invention concerne également une molécule d'acide nucléique codant pour l'anticorps, un vecteur d'expression et une cellule hô</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng ; fre |
| recordid | cdi_epo_espacenet_WO2024250605A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | ANTIBODY BINDING TISSUE FACTOR PATHWAY INHIBITOR AND USE OF ANTIBODY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T14%3A33%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WU,%20Cui&rft.date=2024-12-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024250605A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |